Market Place
Sourcing Support
DoP Rejects Review Applications on Metoprolol Pricing
24 Oct 2024 //
PHARMABIZ
Lupin`s Pune-based biotech facility gets 5 observations from US FDA
05 Oct 2024 //
BUSINESS STD
Lupin receives EIR from USFDA for its Dabhasa facility
13 Jul 2024 //
INDIANPHARMAPOST
Lupin receives EIR from US FDA for its Somerset manufacturing facility
24 Jun 2024 //
PHARMABIZ
Lupin receives EIR from US FDA for its Aurangabad manufacturing facility
24 Apr 2024 //
PHARMABIZ
US FDA makes observation on Lupin`s Aurangabad plant
15 Mar 2024 //
MONEY CONTROL
Lupin Pharma Issues Voluntary Nationwide Recall of 2 Lots of TydemyTM
29 Jul 2023 //
PR NEWSWIRE
FDA inspection at Lupin site uncovers breakdowns left data questions
17 Apr 2023 //
ENDPTS
Lupin`s Vizag unit gets no observations from USFDA
10 Mar 2023 //
ECONOMIC TIMES
Lupin receives USFDA`s establishment inspection report for its Nagpur facility
17 Feb 2023 //
ECONOMIC TIMES
Lupin Limited Unit 1 on Health Canada Inspection List
15 Feb 2023 //
HEALTH CANADA
Lupin recalls over 16k bottles of generic tuberculosis drug in US
21 Jan 2023 //
ECONOMIC TIMES
Lupin Gets Two Observations From USFDA For Somerset Facility
16 Jan 2023 //
INDIA INFOLINE
Lupin in hot water with FDA on production shortfalls—again
19 Apr 2022 //
FIERCEPHARMA
Lupin gets four observations on USFDA inspection at Tarapur facility
05 Apr 2022 //
BUSINESS-STANDARD
Lupin’s Goa manufacturing plant gets EIR from US FDA
13 Dec 2021 //
EXPRESSPHARMA
Lupin recalls 4,113 cartons of oral contraceptive medicine in US market
11 Dec 2021 //
ECONOMICTIMES
USFDA issues 13 observations after inspection of Lupin arm`s facility in US
10 Nov 2020 //
BUSINESS-STANDARD
Metformin recalls continue as Bayshore pulls diabetes drug on carcinogen scare
21 Aug 2020 //
FIERCEPHARMA
Lupin, Sun Pharma recall Lisinopril and Clonazepam respectively in the US market
10 Aug 2020 //
ECONOMIC TIMES
Lupin recalls 35,928 bottles of generic antibiotic drug `Cefdinir` in US market
31 Jul 2020 //
ECONOMICTIMES
Lupin recalls diabetes treatment drug in US
07 Jul 2020 //
ECONOMICTIMES
Unichem, Lupin recall high blood pressure drugs from US over quality issues
21 Jun 2020 //
BUSINESS-STANDARD
Plan to approach USFDA for re-inspection of key plants in next few months: Lupin
16 Jun 2020 //
ECONOMIC TIMES
FDA names five companies recalling NDMA-contaminated metformin
15 Jun 2020 //
RAPS
Lupin Pharma Issues Voluntarily Nationwide Recall of One Lot of Metformin HCL
10 Jun 2020 //
PRNEWSWIRE
US FDA’s relaxation in inspections augurs well for Indian pharma exports
24 May 2020 //
PHARMABIZ
Lupin’s Vizag API facility receives EIR from US FDA
13 May 2020 //
PHARMABIZ
Lupin pharma receives EIR from USFDA for Mandideep Unit II facility
14 Apr 2020 //
BUSINESS-STANDARD
Lupin gets EIR from USFDA for its manufacturing plant in Nagpur
13 Apr 2020 //
BUSINESS-STANDARD
Lupin receives EIR from US FDA for inhalation research center in Florida
30 Mar 2020 //
PHARMABIZ
Lupin denies quality is a company-wide issue despite run ins with FDA
18 Feb 2020 //
IN-PHARMATECHNOLOGIST
USFDA inspection of Lupin`s Aurangabad facility completed with no observation
17 Feb 2020 //
MONEYCONTROL
FDA continues to ride Lupin over plant failings
05 Feb 2020 //
FIERCE PHARMA
Lupin`s Pithampur facility successfully concludes UK MHRA inspection
28 Jan 2020 //
BUSINESS-STANDARD
USFDA classifies inspection of Lupin`s Tarapur facility as `OAI`
13 Jan 2020 //
ECONOMICTIMES
Lupin receives EIR from US FDA for Nagpur facility
19 Oct 2019 //
PHARMABIZ
Japan issues GMP Certificate to Lupin’s Mandideep facility
12 Oct 2019 //
BIOSPECTRUMASIA
Lupin gets 3 observations from USFDA for its Tarapur facility
24 Sep 2019 //
ECONOMICTIMES
Glenmark recalls products from US market
26 Aug 2019 //
ECONOMICTIMES
Lupin gets Establishment Inspection Report from FDA for Aurangabad facility
05 Aug 2019 //
BUSINESS-STANDARD
Lupin recalls over 18k bottles of antibiotic drug in US
17 Jun 2019 //
ECONOMIC TIMES
Lupin`s Goa facility may face regulatory action, says USFDA
30 May 2019 //
LIVEMINT
Lupin`s Goa plant may face regulatory action, says USFDA after inspection
28 May 2019 //
BUSINESS-STANDARD
Lupin receives EU GMP certificate for Mammalian facility in Pune
27 May 2019 //
FDA
Lupin declines 5% as USFDA classifies inspection as OAI
27 May 2019 //
MONEYCONTROL
Rising OAIs bring spotlight back on regulatory compliance at Indian pharma
21 May 2019 //
MONEYCONTROL
Lupin to review US lawsuit accusing it of price fixing, customer allocation
15 May 2019 //
BUSINESS-STANDARD
Lupin gets four observations from USFDA for pharmacovigilance inspection
15 May 2019 //
BUSINESS-STANDARD
Lupin gets govt nod for more time to complete project in Indore SEZ
09 May 2019 //
BUSINESS-STANDARD
Lupin recalls over 12K cartons of birth control tablets from US market
08 Apr 2019 //
ECONOMIC TIMES
Lupin gains as USFDA completed inspection without any observations
03 Apr 2019 //
MONEYCONTROL
USFDA completes inspection of Lupin’s Pithampur Unit-2 (Indore) facility
29 Jan 2019 //
PRESS RELEASE
Lupin gets 6 observations from USFDA for its Pithampur Unit-2
29 Jan 2019 //
ECONOMIC TIMES
A wave of drug recalls hits Indian pharma firms in US
09 Jan 2019 //
DNA INDIA
FDA gets specific on data integrity rules; Lupin, Dishman tagged with 483s
14 Dec 2018 //
FIERCE PHARMA
US FDA completes inspection of Lupin’s Mandideep location
13 Dec 2018 //
PRESS RELEASE
Lupin gets EIR from USFDA for Pithampur facility unit
10 Dec 2018 //
ECONOMIC TIMES
USFDA makes 22 observations post inspection of Lupin`s Mandideep facilities
06 Dec 2018 //
ECONOMIC TIMES
Valsartan products not currently recalled - Updated November 27, 2018
28 Nov 2018 //
FDA
